Akari Tajima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Akari Tajima has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Akihiro Tokushige
Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan
2 shared publications - Akiko Yoshikawa
Jinaikai Ueyama Hospital, Kagoshima 890-0073, Japan
2 shared publications - Ayumi Shintani
Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan
2 shared publications - Hisako Yoshida
Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
2 shared publications - Kazuyuki Kubota
Keishinkai Kubota Internal Medicine Clinic, Kagoshima 892-0871, Japan
2 shared publications - Keisuke Shibata
Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan
2 shared publications
Latest Publications
- Open Access
Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial
Background/Objectives: We aimed to evaluate the efficacy and safety of a short-term dietary intervention using trigonelline-rich Sakurajima radish on vascular endothelial function in patients with metabolic syndrome (MetS). Methods: In this multicenter, open-label, randomized, three-period crossover phase IIb trial, 21 patients with MetS were assigned to three 14-day sequences (Sakurajima radish powder, Aokubi radish powder, and a usual diet), separated by 14-day washouts. The primary outcome was flow-mediated dilation (FMD). Key Secondary outcomes included blood pressure (BP), urinary nitric oxide metabolites (NOx), and the oxidative stress marker 8-hydroxy-2′-deoxyguanosine (8-OHdG). Results: Sakurajima radish did not improve FMD versus the usual diet (p = 0.58) or Aokubi radish (p = 0.59), although a significant negative carryover effect following the Aokubi period likely confounded this estimation. Despite successfully stimulating NO production (elevated urinary NOx, p = 0.03), the intervention paradoxically increased oxidative stress (elevated 8-OHdG/creatinine, p = 0.02) and significantly elevated systolic BP compared with the usual diet (+9.67 mmHg, p = 0.03) and Aokubi radish (+8.86 mmHg, p = 0.04). Conclusions: Sakurajima radish does not appear to improve endothelial function in patients with MetS within the constraints of this short-term crossover design. Importantly, the unexpected negative carryover effect inherently limits the interpretability of this primary FMD outcome, as it may have masked potential physiological benefits. Despite boosting NO production, the intervention paradoxically exacerbated systemic oxidative stress and elevated systolic BP. These findings suggest that in the pro-oxidant environment of MetS, NO-boosting functional foods may induce unintended adverse hemodynamic responses, underscoring the need for careful risk–benefit evaluation and parallel-group trial designs in this specific population.
Open AccessEfficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial
Background/Objectives: We aimed to evaluate the efficacy and safety of a short-term dietary intervention using trigonelline-rich Sakurajima radish on vascular endothelial function in patients with metabolic syndrome (MetS). Methods: In this multicenter, open-label, randomized, three-period crossover phase IIb trial, 21 patients with MetS were assigned to three 14-day sequences (Sakurajima radish powder, Aokubi radish powder, and a usual diet), separated by 14-day washouts. The primary outcome was flow-mediated dilation (FMD). Key Secondary outcomes included blood pressure (BP), urinary nitric oxide metabolites (NOx), and the oxidative stress marker 8-hydroxy-2′-deoxyguanosine (8-OHdG). Results: Sakurajima radish did not improve FMD versus the usual diet (p = 0.58) or Aokubi radish (p = 0.59), although a significant negative carryover effect following the Aokubi period likely confounded this estimation. Despite successfully stimulating NO production (elevated urinary NOx, p = 0.03), the intervention paradoxically increased oxidative stress (elevated 8-OHdG/creatinine, p = 0.02) and significantly elevated systolic BP compared with the usual diet (+9.67 mmHg, p = 0.03) and Aokubi radish (+8.86 mmHg, p = 0.04). Conclusions: Sakurajima radish does not appear to improve endothelial function in patients with MetS within the constraints of this short-term crossover design. Importantly, the unexpected negative carryover effect inherently limits the interpretability of this primary FMD outcome, as it may have masked potential physiological benefits. Despite boosting NO production, the intervention paradoxically exacerbated systemic oxidative stress and elevated systolic BP. These findings suggest that in the pro-oxidant environment of MetS, NO-boosting functional foods may induce unintended adverse hemodynamic responses, underscoring the need for careful risk–benefit evaluation and parallel-group trial designs in this specific population.
- Open Access
- 28 April 2026
- Published by MDPI AG in Preprints.org
Clinical Trial on the Efficacy and Safety of Sakurajima Radish for Vascular Endothelial Function: A Phase IIb Open-Label, Randomized, Three-Sequence Three-Period Crossover Study with Regular Diet and Aokubi Radish Controls
Background/Objectives: We aimed to evaluate the efficacy and safety of trigonelline-rich Sakurajima radish on vascular endothelial function in patients with metabolic syndrome (MetS). Methods: In this multicenter, open-label, randomized, three-period crossover phase IIb trial, 21 patients with MetS were assigned to three 14-day sequences: Sakurajima radish powder, Aokubi radish powder, and a usual diet, separated by 14-day washouts. The primary outcome was flow-mediated dilation (FMD). The secondary outcomes included blood pressure (BP), urinary nitric oxide metabolites (NOx), and oxidative stress markers (8-hydroxy-2′-deoxyguanosine [8-OHdG]). Results: Twenty-one participants were included in this study. Sakurajima radish did not significantly improve FMD compared with the usual diet (control) (p = 0.58) or Aokubi radish (p=0.59). Unexpectedly, systolic BP was significantly higher with Sakurajima radish compared with control (+9.67 mmHg, p = 0.03) and Aokubi radish (+8.86 mmHg, p = 0.04). Urinary 8-OHdG/creatinine levels were also significantly higher with Sakurajima radish compared with control (p = 0.02), despite a significant elevation in urinary NOx levels (p = 0.03). A significant negative carryover effect on FMD was observed after the Aokubi radish period. Conclusions: Consumption of Sakurajima radish does not improve endothelial function in patients with MetS. Contrary to expectations, the intervention is associated with increased systolic BP and oxidative stress, despite elevated NOx levels. These findings suggest the need for caution regarding its cardiovascular application in patients with MetS .
- 28 April 2026
- Published by MDPI AG in Preprints.org
Open AccessClinical Trial on the Efficacy and Safety of Sakurajima Radish for Vascular Endothelial Function: A Phase IIb Open-Label, Randomized, Three-Sequence Three-Period Crossover Study with Regular Diet and Aokubi Radish Controls
Background/Objectives: We aimed to evaluate the efficacy and safety of trigonelline-rich Sakurajima radish on vascular endothelial function in patients with metabolic syndrome (MetS). Methods: In this multicenter, open-label, randomized, three-period crossover phase IIb trial, 21 patients with MetS were assigned to three 14-day sequences: Sakurajima radish powder, Aokubi radish powder, and a usual diet, separated by 14-day washouts. The primary outcome was flow-mediated dilation (FMD). The secondary outcomes included blood pressure (BP), urinary nitric oxide metabolites (NOx), and oxidative stress markers (8-hydroxy-2′-deoxyguanosine [8-OHdG]). Results: Twenty-one participants were included in this study. Sakurajima radish did not significantly improve FMD compared with the usual diet (control) (p = 0.58) or Aokubi radish (p=0.59). Unexpectedly, systolic BP was significantly higher with Sakurajima radish compared with control (+9.67 mmHg, p = 0.03) and Aokubi radish (+8.86 mmHg, p = 0.04). Urinary 8-OHdG/creatinine levels were also significantly higher with Sakurajima radish compared with control (p = 0.02), despite a significant elevation in urinary NOx levels (p = 0.03). A significant negative carryover effect on FMD was observed after the Aokubi radish period. Conclusions: Consumption of Sakurajima radish does not improve endothelial function in patients with MetS. Contrary to expectations, the intervention is associated with increased systolic BP and oxidative stress, despite elevated NOx levels. These findings suggest the need for caution regarding its cardiovascular application in patients with MetS .